Guangxi Wuzhou Zhongheng Group, Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guangxi Wuzhou Zhongheng Group, Ltd. with three other
companies in this sector in China:
Jilin Aodong Medicine Industry (Group) Co., Ltd.
sales of 3.32 billion Chinese Renmimbi [US$495.81 million]
of which 95%
was Pharmaceutical Manufacturing),
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
(3.33 billion Chinese Renmimbi [US$496.44 million]
Guangdong Taiantang Pharmaceutical Co Ltd
(3.31 billion Chinese Renmimbi [US$494.18 million]
of which 70%
was Medicine Wholesale & Retail).
During the year ended December of 2018, sales at
Guangxi Wuzhou Zhongheng Group, Ltd. were 3.30 billion Chinese Renmimbi (US$491.98 million).
increase of 61.2%
versus 2017, when the company's sales were 2.05 billion Chinese Renmimbi.
This was the third consecutive year of growth at Guangxi Wuzhou Zhongheng Group, Ltd..
Sales of Pharmaceutical Segment saw an increase
66.4% in 2018, from
1.90 billion Chinese Renmimbi to 3.15 billion Chinese Renmimbi.
Not all segments of Guangxi Wuzhou Zhongheng Group, Ltd. experienced an increase in sales in 2018:
sales of Real Estate fell 14.6% to 29.84 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).